CLOV vs STXS · rev $1.37B vs rev $26.9M
Clover Health Investments Corp (CLOV) versus Stereotaxis Inc (STXS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Stereotaxis Inc (STXS) is a medical instruments & supplies company listed on AMEX.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported STXS revenue for 2024-12-31 was $26.9M. Net income was -$24.0M. Revenue was up 0.5% from 2023-12-31 to 2024-12-31. STXS currently screens at market cap $174.0M.
CLOV currently screens at market cap $1.55B. STXS currently screens at market cap $174.0M.
Not investment advice. Open the CLOV and STXS stock pages for the full models.
Not investment advice.